![]()
|
|
||||||||
J. Biol. Chem., Vol. 283, Issue 21, 14600-14609, May 23, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||








1
From the
Department of Pharmacology, University of Illinois Cancer Center, University of Illinois College of Medicine, Chicago, Illinois 60612,
Systems Biology Division, The Wistar Institute, Philadelphia, Pennsylvania 19104, and the ¶Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130
Dematin and adducin are actin-binding proteins located at the spectrin-actin junctions, also called the junctional complex, in the erythrocyte membrane. Here we propose a new model whereby dematin and adducin link the junctional complex to human erythrocyte plasma membrane. Using a combination of surface labeling, immunoprecipitation, and vesicle proteomics approaches, we have identified glucose transporter-1 as the receptor for dematin and adducin in the human erythrocyte membrane. This finding is the first description of a transmembrane protein that binds to dematin and adducin, thus providing a rationale for the attachment of the junctional complex to the lipid bilayer. Because homologues of dematin, adducin, and glucose transporter-1 exist in many non-erythroid cells, we propose that a conserved mechanism may exist that couples sugar and other related transporters to the actin cytoskeleton.
Received for publication, September 18, 2007 , and in revised form, March 7, 2008.
* This work was supported, in whole or in part, by National Institutes of Health Grants HL051445 (to A. H. C.) and HL38794 (to D. W. S.). This work was also supported by the American Heart Association, Southeast Affiliate, Award 0555389B (to B. C. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables 1 and 2.
1 To whom correspondence should be addressed: University of Illinois Cancer Center, MC-704, 909 South Wolcott Ave., Chicago, IL 60612-3725. Tel.: 312-355-1293; E-mail: chishti{at}uic.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |